Skin-Care Claims Before And After FDA Warning Letters

A side-by-side comparison of product claims cited in FDA warning letters and updated claims being used by recipients following their compliance work with the agency. The analysis could provide cues as to promotional language that can be employed without provoking a regulatory response.

There’s no guarantee that skin-care marketers warned by FDA in 2015 for website claims identifying their products as unapproved drugs are compliant now from the agency’s point of view.

However, consistencies can be found in companies’ claims revisions following FDA warnings, some of which have been formally closed out...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Archive

More from HBW Insight